000 02252 a2200637 4500
005 20250515235346.0
264 0 _c20101029
008 201010s 0 0 eng d
022 _a1365-2249
024 7 _a10.1111/j.1365-2249.2010.04203.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDocena, G
245 0 0 _aDown-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.
_h[electronic resource]
260 _bClinical and experimental immunology
_cOct 2010
300 _a108-15 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aBlotting, Western
650 0 4 _aCells, Cultured
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aInflammation Mediators
_xmetabolism
650 0 4 _aInflammatory Bowel Diseases
_xenzymology
650 0 4 _aInterleukin-1beta
_xmetabolism
650 0 4 _aInterleukin-6
_xmetabolism
650 0 4 _aIntestinal Mucosa
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNiacinamide
_xpharmacology
650 0 4 _aOrgan Culture Techniques
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aPyridines
_xpharmacology
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aTumor Necrosis Factor-alpha
_xmetabolism
650 0 4 _aYoung Adult
650 0 4 _ap38 Mitogen-Activated Protein Kinases
_xantagonists & inhibitors
700 1 _aRovedatti, L
700 1 _aKruidenier, L
700 1 _aFanning, A
700 1 _aLeakey, N A B
700 1 _aKnowles, C H
700 1 _aLee, K
700 1 _aShanahan, F
700 1 _aNally, K
700 1 _aMcLean, P G
700 1 _aDi Sabatino, A
700 1 _aMacDonald, T T
773 0 _tClinical and experimental immunology
_gvol. 162
_gno. 1
_gp. 108-15
856 4 0 _uhttps://doi.org/10.1111/j.1365-2249.2010.04203.x
_zAvailable from publisher's website
999 _c20067055
_d20067055